IJCS | Volume 33, Nº4, July and August 2020

falsification, and plagiarism) is directly related to the urge to publish more 7 and has affected prestigious medical journals since the beginning of the pandemic. The New England Journal of Medicine and The Lancet are among the oldest, most respected and most influential medical journals in the world. Both journals had important COVID-19 papers 8,9 retracted due to data fabrication. Most of the time, reviewers do not examine the raw data of the studies they review. One of the multiple benefits of Open Science is that research data can be checked by anyone who accesses the data repository, thereby reducing the likelihood of scientific misconduct. 10 What is the role of cardiology journals during COVID-19 pandemic? First, theymust adapt to the urgent needs of fast peer reviewand editorial evaluation. Second, cardiology journals must ensure scientific rigor and research integrity. Third, they must focus on the cardiac aspects of COVID-19 because the cardiology community needs reliable resources of specific information related to their practice, such as the influence of previous heart conditions, safe cardiological practices, cardiac effects of COVID-19 therapy, typical cardiac manifestations of COVID-19, the effects of quarantine on the cardiovascular system and many other emerging issues. Fourth, and finally, non-COVID-19 cardiac research must not be forgotten. All cardiac diseases and their consequences still exist, and many unmet needs of non-COVID-19 cardiac diseases must be pursued. Science must provide answers for these and many other questions. Cardiology journals must accomplish their mission and provide their readers with comprehensive knowledge on cardiovascular sciences in the best way possible. 1. Bauchner H, Fontanarosa PB, Golub RM. Editorial Evaluation and peer review during a pandemic. JAMA.2020 June 26;(online). Doi: 10.1001/ jama.2020.11764 2. Yuen KS, Ye ZW, Fung SY, Chan CP, JinDY. SARS-CoV-2 and COVID-19: the most important research questions. Cell Biosci.2020;10(40):1-5. 3. Moreira LFP. The importance of scientific publications in times of pandemic crisis. Clinics. 2020;76 Doi: 10.6061/clinics/2020/e1895 bg 4. Oliveira GMM, Pinto FJ. COVID-19: a matter close to the heart , Int J Cardiovasc Sci. 2020;33(3):199-202. 5. Mesquita CT, Oliveira A, Seixas FL, Paes A. Infodemia, fake news and medicine : sciece and the quest for truth. Int J Cardiovasc Sci. 2020;33(3):203-5. 6. Horbach SPJM.Pandemic publishing medical journals drastically speed up their publication process for COVID-1. bioRxiv Doi:10.1101/2020.04.18.045963 7. Mesquita CT. Integrity in Scientific Research. Int J Cardiovasc Sci. 2017;30(1):1-3. 8. Mehra MR, Desai SS, Ruschitzka F, Patel NA. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020 May 22. Doi: 10.016/S0140- 6736(20)31180-6 9. Mehra MR, Desai SS, Kuy S, Henry TD, Patel NA. Cardiovascular disease,drug therapy and mortality in COVID-19. N Engl J Med. 2020 Jun 18;382(25):e102. Doi: 10.1056/NEJMoa2007621. Epub 2020,May1 10. Mesquita CT, Borim D, Rochitte CE. Open science,cardiology and 20 years of SciELO (Scientific Electronic Library Online) Int J Cardiovasc Sci. 2019;32(3):203-4. References 306 Tinoco Open science and the role of cardiology journals Int J Cardiovasc Sci. 2020; 33(4):305-306 Editorial This is an open-access article distributed under the terms of the Creative Commons Attribution License